Shanghai, China

Wenke Wang

USPTO Granted Patents = 1 

 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Wenke Wang in Aromatic Compounds

Introduction

Wenke Wang is an accomplished inventor based in Shanghai, China. He has made significant contributions to the field of aromatic compounds, particularly in the development of methods for their preparation and use in treating nervous system diseases. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing pharmaceutical technology.

Latest Patents

Wenke Wang holds a patent for an aromatic compound and its preparation method. The patent, titled "Aromatic compound and preparation method therefor and use thereof," details a compound represented by a specific general formula. This invention includes various forms of the compound, such as tautomers, enantiomers, diastereomers, racemates, and pharmaceutically acceptable salts. The patent emphasizes the compound's potential application in the treatment of nervous system diseases, highlighting its therapeutic significance.

Career Highlights

Wenke Wang is associated with Shanghai Zhigen Pharmaceutical & Technology Co., Ltd., where he applies his knowledge and skills in pharmaceutical research and development. His work at the company reflects his commitment to innovation and improving healthcare solutions through scientific advancements.

Collaborations

Wenke Wang collaborates with talented professionals in his field, including his coworker Tao Xue. Their partnership exemplifies the collaborative spirit that drives innovation in the pharmaceutical industry.

Conclusion

Wenke Wang's contributions to the field of aromatic compounds demonstrate his innovative spirit and dedication to improving medical treatments. His patent reflects a significant advancement in pharmaceutical technology, showcasing the potential for new therapies in addressing nervous system diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…